Company: ANIX
Filing Date: 2025-09-10
Form Type: 10-Q
Source: 0001493152-25-013000
Chunk: 50

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: 10-Q
Item: Part I, Item 8
Chunk 50
---
,000  
     2.7  
    $3.93 

    11

2018
Share Plan

The
2018 Share Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards,
performance awards and stock units to employees, directors and consultants. As of July 31, 2025, the 2018 Share Plan had 656,642 shares
available for future grants. Information regarding the 2018 Share Plan for the nine months ended July 31, 2025 is as follows:

 SCHEDULE OF OPTION ACTIVITY

    Shares  
    Weighted
     Average Exercise  Price Per Share  
    Aggregate
     Intrinsic Value (in thousands) 
  
    Options
    outstanding at October 31, 2024 
     11,171,094  
    $3.74  

    Granted 
     1,430,000  
     2.41  

    Exercised 
     (35,000) 
     2.09  

    Forfeited/expired 
     (90,000) 
     3.54  

    Options
    outstanding at July 31, 2025 
     12,476,094  
    $3.59  
    $1,707 
  
    Options
    exercisable at July 31, 2025 
     8,943,235  
    $3.61  
    $972 

The
following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of July 31, 2025:

 SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE

    Options
    Outstanding  
    Options
    Exercisable 
  
    Range
    of  Exercise Prices  
    Number
     Outstanding  
    Weighted
     Average  Remaining  Contractual Life  (in years)  
    Weighted
     Average  Exercise Price  
    Number
     Exercisable  
    Weighted
     Average  Remaining  Contractual Life  (in years)  
    Weighted
     Average  Exercise Price 
  
    $
    2.09
    - $3.87  
     6,638,879  
     5.7  
    $3.06  
     5,439,